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Abstract
Between 2006 and 2009, all MRSA isolates recovered from
human patients in Upper Austria were subjected to molecular
biological analysis. Whereas the isolate number decreased from
year to year, the proportion of the most common sequence
types (ST5, ST8 and ST22) as well as the frequency of associated
PFGE subtypes and spa-types remained similar. The rate of PVL-
positive MRSA increased, whereupon the most common
sequence types were ST152, ST8 including clone USA300, ST5,
ST777 and ST88. The frequency of ST398 was high (25%) in
relation to the PVL-positive clones. Thus, we consider a special
focus on community-associated MRSA to be necessary.
Keywords: Austria, MRSA, PVL, typing, USA300
Original Submission: 27 May 2010; Revised Submission:
9 September 2010; Accepted: 9 September 2010
Editor: G. Lina
Article published online: 20 September 2010
Clin Microbiol Infect 2011; 17: 920–923
10.1111/j.1469-0691.2010.03376.x
Corresponding author: K. Krziwanek, National Reference Centre
for Nosocomial Infections and Antibiotic Resistance, Department of
Hygiene, Microbiology and Tropical Medicine, Elisabethinen Hospital
Linz, Fadingerstrasse 1, A-4010 Linz, Austria
E-mail: karina.krziwanek@gmx.net
*University Professor Dr Helmut Mittermayer unexpectedly died on
6 July 2010, during a conference in Stockholm.
920 Clinical Microbiology and Infection, Volume 17 Number 6, June 2011 CMI
ª2010 The Authors
Clinical Microbiology and Infection ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 915–927
Methicillin-resistant Staphylococcus aureus (MRSA) is one of
the most important human pathogens. About one-third of all
human individuals is colonized with S. aureus and infections
can affect all tissues and anatomical sites [1]. Furthermore,
MRSA can be acquired not only in, but also, with increasing
frequency, outside of health care facilities.
The Austrian federal province Upper Austria has an MRSA
surveillance project that is called ‘MRSA-Registry Upper
Austria’. This project has existed since 2006 and aims to
systematically compile and analyse the data on all human
MRSA isolates that have been collected there. All nine Upper
Austrian laboratories and all 22 Upper Austrian hospitals
take part in this project. In this study, we investigated, for
the ﬁrst time, the trend in the occurrence of MRSA types
and subtypes in Upper Austria within a time period of
4 years.
Between January 2006 and December 2009, we received
all collected primary clinical MRSA isolates (one isolate per
person per hospitalization; one isolate per outpatient per
6 months) from the participating hospitals and laboratories.
Each hospital had its own protocol for taking samples for
molecular biological diagnostics. Thus, the isolates were
comprised of samples from patients with infection (48.7%) as
well as from patients with colonization (47.6%); some iso-
lates could not be categorized (3.8%).
All isolates were cultured and analysed as described [2,3].
Brieﬂy, DNA was isolated and PCR was used to detect the
presence of mecA and femA as well as the PVL genes lukS-
lukF. SmaI macrorestriction digestion was performed with
subsequent PFGE. Additionally, isolates were analysed by
spa-typing and, if necessary, multi-locus sequence typing
(MLST) as described [4]. USA300 isolates were conﬁrmed by
multiplex PCR-based agr grouping [5] and detection of the
ACME gene cluster by arcA-PCR [6].
We received 1492 human primary MRSA isolates. The iso-
late number decreased over time (2006, n = 461; 2007,
n = 374; 2008, n = 385; 2009, n = 272). This is in accordance
with other data for Austria (MRSA bacteraemia decreased
from 15.3% in 2003 to 7.5% in 2008 [7]), as well as with
trends in other European countries [8]. As shown in Fig. 1,
30 different MRSA types were detected using PFGE as well
as MLST. Interestingly, the frequency of ST5, ST8 and ST22
remained fairly constant over time. This indicates that these
sequence types have probably some selective advantages, and
are therefore not replaced by others.
In more detail, we detected predominant PFGE subtypes
within these main MRSA sequence types that also remained
similarly frequent: ST5 – subtype 2 (48.3% mean), ST8 – sub-
type 1 (78.8% mean), ST8 Austrian clone – subtype 0 (51.7%
mean), and ST22 – subtype 0 (54.0% mean). These data
suggest that it is not the sequence type as a whole, but only
a single strain that has selection advantages. The differences
between these predominant and other strains should be
further investigated.
Within the group of predominant sequence types, ST228
was exceptional in that its proportion within the group of all
MRSA isolates decreased, it was multifarious, and showed no
predominant PFGE-subtypes (in contrast to spa-type, see
below).
Comparable to the PFGE-subtypes, also the main spa-
types of the predominant sequence types (including ST228)
remained the predominant types, although their proportions
varied (Fig. 1).
The proportion of PVL-positive isolates began to increase
in 2008 (2006, 8.0%; 2007, 5.6%; 2008, 6.2%; 2009, 11.8%),
which corresponds to tendencies in countries with low
MRSA rates [9,10]. However, compared with, for example,
Germany (1.74% from 2003 to 2006) [9], the Upper Austrian
PVL-positive MRSA rates were rather high. One reason for
this might be the decrease of the total MRSA rate in Upper
Austria. Even stable amounts of PVL-positive MRSA would
imply an increase in the proportion of PVL-positive MRSA
relative to total MRSA.
As shown in Fig. 2, most of the PVL-positive isolates
belonged to ST152, which is still a relatively rare sequence
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FIG. 1. Proportion of the ﬁve most common MRSA sequence types
and their corresponding main spa-types in Upper Austria from 2006
to 2009. These ﬁve types represented 85.1% of all isolates. The table
lists the mean percentage of each sequence type with regard to all
MRSA isolates, and for each sequence type the percentage of its
most common spa-type. ST8 Austrian clone is described in Krziw-
anek et al. [2] (the main difference to other ST8 clones is the PFGE-
pattern and spa-type). The following sequence types were also
detected: ST1, ST30, ST34, ST36, ST39, ST45, ST72, ST80, ST88,
ST97, ST152, ST217, ST225, ST239, ST247, ST254, ST398, ST449,
ST617, ST772, ST777, ST778, ST1430 and ST1473.
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type in Europe and for which HA-MRSA isolates have not
been reported so far. It is distributed across the middle of
Europe, from the Balkans to Saxony, and has also been
reported in Mali [11]. The second and third most common
PVL-positive strains belonged to sequence types ST8 and
ST5. PVL-positive ST8, especially the clone USA300 (deﬁned
as CC8/ST8/t008, PVL-positive and ACME-positive, charac-
teristic PFGE-pattern; 76.2% of all PVL-positive ST8), was the
main cause of the increase of the PVL-positive MRSA.
Although relative to all MRSA isolates the proportion of
USA300 isolates was low, it increased steadily from 0.4% in
2006 to 2.2% in 2009. This increase and the fact that
USA300 was also reported from the Austrian provinces Salz-
burg, Lower Austria and Vienna [12] should be a focus of
future attention. Although the 100% PVL-positive sequence
type CC59/ST777 is rarely reported in Europe, the corre-
sponding spa-type t437 is detected in many European coun-
tries, New Zealand, Taiwan and China (http://www.ridom.de/
spaserver). Due to the same spa-type and similar PFGE-
patterns compared with Coombs et al. [13], our ST777
strains seem to be related to Taiwan Clone ST59-V. Inter-
estingly, the widely disseminated European clone ST80
occurred only to a low extent in Upper Austria.
Acting on the assumption that PVL can be used as a mar-
ker for CA-MRSA [3,9], the biggest part of all of the Upper
Austrian CA-MRSA was represented by the animal-associated
clone ST398, as shown in Fig. 2. This is in contrast to obser-
vations of Witte from Germany, who describes ST398 as rare
relative to PVL-positive CA-MRSA [9]. The proportion of
ST398 among our MRSA isolates varied between 1.5% and
3.7%, showing no upward- or downward tendency.
In conclusion, the MRSA population in Upper Austria is
not as dynamic as might be expected. No matter which typ-
ing method was used, the predominant MRSA clonal lineages,
PFGE-subtypes and spa-types identiﬁed in 2006 remained the
most frequent ones until 2009 and were not replaced by
minor clones. The increase in the proportion of PVL-positive
isolates since 2007 is partly a consequence of the occurrence
of USA300 in Austria and partly due to decreasing HA-
MRSA rates. Our data suggest that MRSA surveillance, with
an additional focus on community-associated MRSA, should
be continued.
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Methicillin-resistant Staphylococcus aureus
(MRSA) ST398 in a farmer with skin lesions
and in pigs of his farm: clonal relationship
and detection of lnu(A) gene
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Abstract
Skin infection associated with methicillin-resistant Staphylococcus
aureus (MRSA)-ST398 was detected in a pig-farmer, and MRSA-
ST398 isolates were also detected in nasal samples of the patient
and of 11/12 pigs on his farm. Twelve MRSA isolates were
obtained from skin lesions (n = 6) and nasal samples (n = 6) of
the patient in two sampling moments and 11 MRSA isolates
from nasal samples of pigs. They were typed as t011-SCCme-
cIVa-agrI and t108-SCCmecV-agrI (patient and pigs) and t588-
SCCmecV-agrI (patient). The following resistance genes were
detected (number isolates): tet(K) (1), tet(L) (23), tet(M) (13),
erm(A) (13), erm(C) (13), msr(A) (11), lnu(A) (21), aph(2¢¢)-
acc(6¢) (3), ant(4¢) (13), aph(3¢) (12), dfrS1 (15) and dfrK (22).
Seventeen human and animal MRSA-ST398 isolates showed
indistinguishable PFGE patterns (A1-spa-t011 or B2-spa-t108)
and similar phenotypic-genotypic characteristics, including the
presence of the lnu(A) gene, associated with lincomycin resis-
tance. Potential pig-to-human transference of ST398 is suggested
in this study. The ﬁrst detection of the lnu(A) gene in MRSA-
ST398 is reported.
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Methicillin-resistant Staphylococcus aureus (MRSA) of
sequence type ST398 has been identiﬁed either colonizing
or causing infections in animals and humans, and has been
found to cause diseases related to occupational contact with
pigs. The prevalence of colonization by these strains in
those who work with pigs has been proved to be higher
than in people without this risk factor [1]. MRSA-ST398 is
characterized by its resistance to tetracycline, one of the
main antibiotics used in pig farming. Moreover, an unusual
resistance phenotype showing clindamycin resistance but
erythromycin susceptibility has been reported in a few
MRSA-ST398 isolates [2–5]. Recently, this phenotype has
been associated in some strains with the presence of plas-
mid-borne resistance genes vga(A) or vga(C) [6]. The
expression of lincomycin-modifying enzymes could confer
resistance to lincomycin but not to erythromycin, and this
mechanism is infrequent in S. aureus, and has not been
reported so far in MRSA-ST398 isolates. The aim of this
study was to perform the genetic characterization of 23
MRSA isolates (12 recovered from a patient with skin
lesions and 11 from pigs on the farm where the patient
worked) in order to determine the possible MRSA
animal-to-human transmission, and to characterize the
mechanism of lincomycin resistance detected in 21 of 23
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